NEW DELHI : India will participate in the World Health Organisation's (WHO) multi-country 'solidarity trial' for developing potential treatments and drugs for COVID-19, the Indian Council of Medical Research (ICMR) said on Friday. "ICMR will collaborate with WHO for public health emergency 'Solidarity Trial' -- an international randomised trial of additional treatments for COVID-19 in hospitalised patients," ICMR said.
It will be coordinated in India by Dr Sheela Godbole, Scientist, ICMR-National AIDS Research Institute in Pune. Earlier on March 27, Dr R Ganga Ketkar of ICMR said that India was likely to participate in the WHO's 'solidarity trial' for a potential treatment for COVID-19.